The Return Of Cupping + Hijama Fed Bloodletting Needle Factories A Second Wave Of Dividends

As a "therapy," bloodletting is a rare case in medical history of "complete death → resurrection → commercialization":

• 1880–1920:​ Virchow's cellular pathology, Pasteur/Koch's microbiology, and Osler's internal medicine swept the four-humor theory into history. Bloodletting became synonymous with the "dark ages of medicine"; barber-surgeons regressed to pure barbers. In Western medicine, bloodletting = dark history.
• 1950s–:​ TCM triangular needles survived in acupuncture departments (though still mostly reusable before 1990, with modest volume); the Islamic world never abandoned Hijama (religious authorization).
• 2016 Rio Olympics:​ Michael Phelps posted Instagram photos of cupping marks on his shoulders and back; Western media ran stories on "Cupping therapy in Olympics." Sports medicine, pain clinics, and rehabilitation departments followed suit. Wet cupping became a paid "alternative medicine + athletic recovery" service in the West (especially California, Germany, Australia), at $60–120 per session.

2020–:​ The long COVID population with muscle pain/fasciitis expanded; cupping gained traction in Western general practice clinics - not TCM departments, but "pain clinics + physio" adopting Hijama-style wet cupping needles.

Incremental Demand This Resurrection Fed to Manufacturers

• Western pain clinic Hijama needle orders:​ Previously, 90% of Hijama needles went to the Middle East/North Africa/Southeast Asia. After 2020, Western orders surged (Germany/Netherlands/US West/Australia), characterized by: "CE MDR required + English IFU + shorter needle length (18–20 mm, moderate Caucasian subcutaneous fat) + medical blue/gray pen colors, NO olive green (in non-Islamic contexts, olive green looks odd)." Unit price $0.15–0.22, 20–30% higher than Middle Eastern orders.
• TCM triangular needles' "export-to-domestic reverse flow":​ 30% of the ~38,000 acupuncture clinics in the US also offer cupping + pricking, sourcing "triangular needles + single-use." Yiwu factories originally selling only domestically/Southeast Asia are now reverse-supplying West Coast acupuncture chains - but these require "FDA registration + English YY 0104 equivalency statement," stricter than domestic orders.
• Sports team customizations:​ NBA/Premier League/Olympic delegation medical kits now routinely stock "wet cupping needles + cups." Customization points: "team logo laser-engraved on handle + team physician name on packaging + 15 mm needle length (athletes have thin subcutaneous fat, and pricking only needs to break superficial veins)." MOQ small (2,000–5,000 pieces) but unit price high ($0.35–0.50), and "same model as XX team" feeds back into civilian-line brand premiums.

Beware the "Bubble"

Cupping in the West remains positioned as "alternative medicine," not covered by insurance (the US CPT codes 97810/97811 exist but reimburse at low rates), so growth is capped by the "out-of-pocket population." Chinese factories should not expand Hijama lines expecting "the next hypodermic" surge - 12–18% annual growth is sustainable, but 30%+ is unrealistic. The prudent approach: "existing Yiwu/Yangzhou lines + 20 million pieces/year flexible capacity," avoiding heavy asset bets.

🏊 For Manufacturers:​ When receiving bloodletting orders from Western pain clinics/acupuncture clinics, the focus is not the "needle" but the "registration pathway" - FDA 510(k) for lancet-class devices, or listing (triangular needles fall under the "acupuncture needle" subclass, for which the FDA has an established pathway); CE MDR as Class IIa. Fewer than 10 domestic Chinese factories currently hold both certifications specifically for bloodletting - this represents a first-mover window.